Skip to Content

The TruScreen Device

Clinical Performance

Development History

Eliminating Cervical Cancer

The TruScreen Device

Clinical Performance

Development History

Eliminating Cervical Cancer

The TruScreen Device

Clinical Performance

Development History

Eliminating Cervical Cancer

Truscreen Limited – 2018 Annual Report

31 July

Written By

TruScreen Announces HIV African Initiative

2018 Annual Review Letter

A world without cervical cancer.

Quick links

The TruScreen Device

Markets & Distributors

Contact

info@truscreen.com

TruScreen Group Limited (NZX/ASX: TRU) is a New Zealand and Australian listed medical device company that has developed an AI-enabled device that can detect precancerous and cancerous cervical changes in real-time via optical and electrical measurements of cervical tissue. Unlike many cervical screening devices, that have only triage/adjunct functionality, the TruScreen device is registered as a stand alone primary screening tool.

© 2025 Truscreen Group Ltd. All rights reserved.